Search
for
Sort by
Research 211–240 of 1000+
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY
- Prostate cancer and androgenic alopecia
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- Effect of ethanol extract of Zapoteca portoricensis stem on liver, kidney and prostatic biomarkers of testosterone-induced benign prostate hyperplasia (BPH) in male albino rats
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- Development and characterization of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with finasteride and in vivo evaluation of their efficacy in hair growth
- DEVELOPMENT OF CHEMICAL FINGERPRINTS TO DIFFERENTIATE THE CONTROVERSIAL INDIAN HERBAL DRUGS ECLIPTA PROSTRATA AND WEDELIA CALENDULACEA (BHRINGRAJA)
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents.
- Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Steroid Hormones of Reproduction and Sexual Development
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Multiple readout assay for hormonal (androgenic and antiandrogenic) and cytotoxic activity of plant and fungal extracts based on differential prostate cancer cell line behavior
- Niosomal delivery of pumpkin seed oil: development, characterisation, and physical stability
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality